Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of miRNA host gene promoter methylation in prostate cancer

6 Apr 2017

Abstract excerpt

Only a part of prostate cancer (PCa) patients has aggressive malignancy requiring adjuvant treatment after radical prostatectomy (RP). Biomarkers capable to predict biochemical PCa recurrence (BCR) after RP would significantly improve preoperative risk stratification and treatment decisions. MicroRNA (miRNA) deregulation has recently emerged as an important phenomenon in tumor development and progression,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Epigenetics and DNA Methylation
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28398479
DOI: 10.1093/hmg/ddx138

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of miRNA host gene promoter methylation in prostate cancerPMID 28398479Read ↗

A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97Semantic proximity Read ↗

MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumorsSemantic proximity Read ↗

Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissueSemantic proximity Read ↗

Promoter Hypermethylation in Prostate CancerSemantic proximity Read ↗

Genome-Wide Methylation Analysis of Prostate Tissues Reveals Global Methylation Patterns of Prostate CancerSemantic proximity Read ↗

Integrative analyses of DNA methylase expression and related immune landscape in Prostate CancerSemantic proximity Read ↗

DNA Methylation in Prostate Cancer: Clinical Implications and Potential ApplicationsSemantic proximity Read ↗

Hypermethylation of the <i>GABRE∼miR-452∼miR-224</i> Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical ProstatectomySemantic proximity Read ↗

Recent advances in understanding DNA methylation of prostate cancerSemantic proximity Read ↗

Methylation and MicroRNA Profiling to Understand Racial Disparities of Prostate Cancer.Semantic proximity Read ↗

Epigenetic silencing of MEIS2 in prostate cancer recurrenceSemantic proximity Read ↗

Global Methylation Profiling for Risk Prediction of Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.